Creative Medical Technology Holdings, Inc. - 8-K Summary
Business Context and Reporting Period
Creative Medical Technology Holdings, Inc., a Nevada corporation, filed this Current Report on Form 8-K on November 8, 2021. The filing reports a material corporate action involving a reverse stock split and amendments to the Company's Articles of Incorporation.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on capital structure changes.
Material Changes
- Reverse Stock Split: The Company effected a 1-for-500 reverse stock split of its common stock.
- Authorized Shares: The authorized number of common shares was reduced from 25 billion to 50 million.
- Effective Date: The split became effective with FINRA on November 10, 2021.
- Trading Symbol: The symbol changed to "CELZD" for 20 business days or until listing on The Nasdaq Capital Market, after which the "D" will be removed.
- CUSIP Number: The CUSIP changed to 22529Y 309.
- Fractional Shares: No fractional shares were issued; holders entitled to fractions received one whole share instead.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure that percentage ownership remains unchanged except for minor rounding adjustments. The primary objective stated is to effect the reverse split to facilitate potential listing on The Nasdaq Capital Market.
Investor Verification Checklist
- Verify the new trading symbol "CELZD" and the removal of the "D" suffix upon Nasdaq listing.
- Confirm the new CUSIP number (22529Y 309) with your broker to ensure proper trade execution.
- Check account statements to confirm the 1-for-500 adjustment and the rounding up of fractional shares to whole shares.
- Review the Company's subsequent filings to confirm successful listing on The Nasdaq Capital Market.